Print Page   |   Contact Us   |   Sign In   |   Register
News & Press: Regulatory Updates

PHSS Sept 2018 Regulatory Update: Brexit preparedness; Responsible Person named; Quality Attribute c

07 September 2018  
Share |

PHSS Regulatory Update September 2018


During the last 4 weeks there have been a number of developments in the regulation of the pharmaceutical industry. This month reported issues have come from the EU, PIC/S and USA regulatory authorities.


The topics covered in this edition of the “Update” include:



  • Brexit preparedness: EMA to further temporarily scale back and suspend activities
  • Update on review of recalled valsartan medicines
  • UK government’s preparations for a March 2019 ‘no deal’ scenario.
  • Responsible Person named on the WDA - Part 3
  • What to expect from GPvP inspections



  • Dissolution testing and acceptance criteria for immediate-release solid oral dosage form drug products containing high solubility drug substances
  • Elemental impurities in drug products
  • Quality Attribute considerations for chewable tablets




  • Jordan applies for PIC/S pre-accession


  • New class of drugs fulfills promise of RNA-based medicine
  • FDA approves first generic version of EpiPen
  • Recall of porcine thyroid API from Sichuan Friendly Pharmaceutical Co., Limited, China

Membership Software Powered by YourMembership  ::  Legal